Health and Care

Scienta Lab

Increasing the efficiency of autoimmune disease research with artificial intelligence? This is now achievable thanks to Scienta Lab.

Vincent Bouget, Camille Bouget, and Julien Duquesne founded Scienta Lab after making two observations. Firstly, the research and development of a new immunology drug costs an average of 500 million euros with an 85% probability of failure, the main difficulty being to understand why the same drug can have very different effects from one patient to another.

Secondly, a large amount of data is collected by hospitals and provides valuable information for modeling the disease.

The startup has therefore implemented a solution that uses this data to accelerate clinical research and development while reducing costs. It is thus building a library of innovative predictive algorithms thanks to cutting-edge databases, breakthrough machine learning expertise, and world-class scientific collaborations.

Scienta Lab collaborates with the immunology research team of Prof. Xavier Mariette (President of the scientific council of Paris-Saclay University), as well as with the MICS laboratory at CentraleSupélec (notably Prof. Cournède).

CentraleSupélec has supported us since our beginnings on several crucial aspects, both scientifically through the support of MICS, and entrepreneurially through the 21st acceleration program!
Vincent Bouget, CEO of Scienta Lab